F2RL1 and psoriasis: observed a substantial increase in the percentage of mast cells expressing PAR2 in the lesional skin of psoriasis compared to the non-lesional skin when analyzing the expression of PAR2 immunoreactivity in mast cells isolated from lesional and non-lesional skin of patients with plaque psoriasis.